First Quadrant’s Inspire Medical Systems INSP Stock Holding History

First Quadrant’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,952	Closed	-$118K	–	625
2019 Q2	$118K	Buy	+1,952	New	+$105K	0.01%	575

Other funds holding INSP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

First Quadrant's INSP Position: Q3 2019 in Review

First Quadrant sold out of Inspire Medical Systems (INSP) in Q3 2019, closing a stake of 1,952 shares — an estimated $118K sold.

First Quadrant first reported a position in INSP in Q2 2019 and held it in 1 quarter. The position peaked at $118K in Q2 2019. 155 funds tracked by Wall St. Rank hold INSP as of Q3 2019.

First Quadrant reported no remaining Inspire Medical Systems position as of Q3 2019 after selling out during the quarter.
First Quadrant sold 1,952 Inspire Medical Systems shares in Q3 2019, an estimated $118K.
First Quadrant first reported a position in Inspire Medical Systems in Q2 2019 and held it in 1 quarter.
First Quadrant's Inspire Medical Systems position peaked at $118K in Q2 2019.
155 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2019.

Based on First Quadrant's 13F filing for Q3 2019, filed 25 Oct 2019.